Progress in Neoadjuvant Therapy for Breast Cancer: Reviewing the Role of Immunotherapy, Endocrine and Anti-Her-2 Therapy
0% Complete
Course Content
Credits
- AMA PRA Category 1 Credit™Non-CME
Course Details
- Duration
- 0.00 hour
- Released
- May 14, 2025
- Last Review
- May 14, 2025
- Expires
- May 14, 2028
Faculty & Disclosure
Faculty
Gregory Vidal, MD
Disclosure
Gregory Vidal, MD discloses no such relationships exist
Accreditation
NA
